Literature DB >> 12232968

Ethics and mental illness research.

Laura Weiss Roberts1.   

Abstract

There are many tasks ahead in the area of ethics and mental illness research. We face unknown challenges in psychiatric genetics projects, studies of psychopharmacological interventions in children, controversial scientific designs (e.g., symptom challenge, medication-free interval), and cross-disciplinary research incorporating goals and methods of health services, epidemiology, and social and behavioral science endeavors. Boundaries between innovative clinical practices and research-related experimentation will become increasingly difficult to distinguish, as will the roles between clinicians, clinical researchers, and basic scientists. Moreover, the institutions and systems in which research occurs are being rapidly and radically revised, raising new questions about oversight responsibilities and standards. Our ability to identify and respond to the ethical questions arising in this uncharted territory will depend on our willingness to self-reflect, to integrate the observations and insights of the past century, to think with great clarity, and to anticipate novel ethical problems that keep company with scientific advancements. It will also depend on data. Empirical study of ethical dimensions of human research is essential to anchor and attune the intuitions and theoretical constructs that we develop. Science and ethics have changed over the past 100 years, as they will over the next century. It is ironic that the ethical acceptability of psychiatric research is so much in question at this time, when it holds so much promise for advancing our understanding of mental illness and its treatment. The tension between the duty to protect vulnerable individuals and the duty to perform human science will continue to grow, as long as ethics and science are seen as separable, opposing forces with different aims championed by different heroes. The profession of psychiatry is poised to move toward a new, more coherent research ethics paradigm in which scientific and ethical issues are recognized as inextricably linked: science as a human activity carries complex ethical meanings and responsibilities, and ethics itself is subject to scrutiny and amenable to scientific inquiry. Building a broader, more versatile, and more effective repertoire of safeguards will be increasingly important, and safeguards, in this view, represent a modest price for the privilege of studying serious illnesses--diseases that cause grave suffering and yet are a source of both vulnerability and strength. In this paradigm, attention to ethics safeguards is no longer understood as a barrier to scientific advancement, but rather as the means by which psychiatric research may be conducted with broad societal support, honorably and, ultimately, with the expectation of bringing benefit to millions of people with mental illness.

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Year:  2002        PMID: 12232968     DOI: 10.1016/s0193-953x(01)00014-4

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  12 in total

Review 1.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

2.  The patient-oriented clinician-researcher: advantages and challenges of being a double agent.

Authors:  Philip T Yanos; Douglas M Ziedonis
Journal:  Psychiatr Serv       Date:  2006-02       Impact factor: 3.084

3.  Challenges associated with controlled psychopharmacological research trials in adolescents with eating disorders.

Authors:  Mark L Norris; Wendy Spettigue; Annick Buchholz; Katherine A Henderson
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2007-11

4.  IRB Member Judgments of Decisional Capacity, Coercion, and Risk in Medical and Psychiatric Studies.

Authors:  Rebecca Luebbert; Raymond C Tait; John T Chibnall; Teresa L Deshields
Journal:  J Empir Res Hum Res Ethics       Date:  2008-03       Impact factor: 1.742

5.  The need for additional safeguards in the informed consent process in schizophrenia research.

Authors:  K K Anderson; S D Mukherjee
Journal:  J Med Ethics       Date:  2007-11       Impact factor: 2.903

6.  Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception.

Authors:  Yan Leykin; Paul P Christopher; Paul E Holtzheimer; Paul S Appelbaum; Helen S Mayberg; Sarah H Lisanby; Laura B Dunn
Journal:  AJOB Prim Res       Date:  2011-10

Review 7.  Research ethics issues in geriatric psychiatry.

Authors:  Laura B Dunn; Sahana Misra
Journal:  Psychiatr Clin North Am       Date:  2009-06

8.  Vulnerability in clinical research with patients in pain: a risk analysis.

Authors:  Raymond C Tait
Journal:  J Law Med Ethics       Date:  2009       Impact factor: 1.718

9.  Treatment Capacity and Clinical Outcomes for Patients With Schizophrenia Who Were Treated With Electroconvulsive Therapy: A Retrospective Cohort Study.

Authors:  Joanne E Plahouras; Gerasimos Konstantinou; Tyler S Kaster; Daniel Z Buchman; George Foussias; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

10.  Ethical and Scientific Perspectives of Placebo-controlled Trials in Schizophrenia.

Authors:  Yuval Melamed; Adiel Doron; Orit Stein-Reisner; Avi Bleich
Journal:  J Clin Med Res       Date:  2009-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.